Eric Dobmeier - Net Worth and Insider Trading
Eric Dobmeier Net Worth
The estimated net worth of Eric Dobmeier is at least $40 Million dollars as of 2024-11-28. Eric Dobmeier is the COO of Seagen Inc and owns about 119,860 shares of Seagen Inc (SGEN) stock worth over $27 Million. Eric Dobmeier is the President, CEO of Chinook Therapeutics Inc and owns about 301,138 shares of Chinook Therapeutics Inc (KDNY) stock worth over $12 Million. Eric Dobmeier is also the Director of Atara Biotherapeutics Inc and owns about 22,533 shares of Atara Biotherapeutics Inc (ATRA) stock worth over $274,452. Besides these, Eric Dobmeier also holds Adaptive Biotechnologies Corp (ADPT) . Details can be seen in Eric Dobmeier's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Eric Dobmeier has not made any transactions after 2023-11-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Eric Dobmeier
Eric Dobmeier Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Eric Dobmeier owns 8 companies in total, including Aduro Biotech Inc (ADRO) , Adaptive Biotechnologies Corp (ADPT) , and Atara Biotherapeutics Inc (ATRA) among others .
Click here to see the complete history of Eric Dobmeier’s form 4 insider trades.
Insider Ownership Summary of Eric Dobmeier
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ADRO | Aduro Biotech Inc | 2020-10-05 | director & President & CEO |
| ADPT | Adaptive Biotechnologies Corp | 2021-01-04 | director |
| ATRA | Atara Biotherapeutics Inc | 2023-11-10 | director |
 | | 2017-05-25 | director |
| | 2017-12-04 | Chief Operating Officer |
| | 2017-06-19 | director |
| | 2023-04-24 | director & President & CEO |
| | 2023-02-02 | director |
Eric Dobmeier Latest Holdings Summary
Eric Dobmeier currently owns a total of 4 stocks. Among these stocks, Eric Dobmeier owns 119,860 shares of Seagen Inc (SGEN) as of December 4, 2017, with a value of $27 Million and a weighting of 68.79%. Eric Dobmeier owns 301,138 shares of Chinook Therapeutics Inc (KDNY) as of April 24, 2023, with a value of $12 Million and a weighting of 30.52%. Eric Dobmeier also owns 22,533 shares of Atara Biotherapeutics Inc (ATRA) as of November 10, 2023, with a value of $274,452 and a weighting of 0.69%. The other 1 stocks Adaptive Biotechnologies Corp (ADPT) have a combined weighting of 0% among all his current holdings.
Latest Holdings of Eric Dobmeier
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SGEN | Seagen Inc | 2017-12-04 | 119,860 | 228.74 | 27,416,776 |
| KDNY | Chinook Therapeutics Inc | 2023-04-24 | 301,138 | 40.39 | 12,162,964 |
| ATRA | Atara Biotherapeutics Inc | 2023-11-10 | 22,533 | 12.18 | 274,452 |
| ADPT | Adaptive Biotechnologies Corp | 2021-01-04 | 0 | 5.73 | 0 |
Holding Weightings of Eric Dobmeier
Eric Dobmeier Form 4 Trading Tracker
According to the SEC Form 4 filings, Eric Dobmeier has made a total of 0 transactions in Seagen Inc (SGEN) over the past 5 years. The most-recent trade in Seagen Inc is the sale of 3,729 shares on December 4, 2017, which brought Eric Dobmeier around $219,079.
According to the SEC Form 4 filings, Eric Dobmeier has made a total of 11 transactions in Chinook Therapeutics Inc (KDNY) over the past 5 years, including 7 buys and 4 sells. The most-recent trade in Chinook Therapeutics Inc is the sale of 25,000 shares on April 24, 2023, which brought Eric Dobmeier around $540,250.
According to the SEC Form 4 filings, Eric Dobmeier has made a total of 1 transactions in Atara Biotherapeutics Inc (ATRA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Atara Biotherapeutics Inc is the acquisition of 17,873 shares on November 10, 2023, which cost Eric Dobmeier around $102,770.
More details on Eric Dobmeier's insider transactions can be found in the Insider Trading History of Eric Dobmeier table.Insider Trading History of Eric Dobmeier
- 1
Eric Dobmeier Trading Performance
GuruFocus tracks the stock performance after each of Eric Dobmeier's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Eric Dobmeier is 34.23%. GuruFocus also compares Eric Dobmeier's trading performance to market benchmark return within the same time period. The performance of stocks bought by Eric Dobmeier within 3 months outperforms 7 times out of 11 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Eric Dobmeier's insider trading performs compared to the benchmark.
Performance of Eric Dobmeier
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 24.84 | | | | | |
| Relative Return to S&P 500(%) | 23.46 | | | | | |
Eric Dobmeier Ownership Network
Eric Dobmeier Owned Company Details
What does Aduro Biotech Inc do?
Who are the key executives at Aduro Biotech Inc?
Eric Dobmeier is the director & President & CEO of Aduro Biotech Inc. Other key executives at Aduro Biotech Inc include 10 percent owner Versant Voyageurs I, L.p. , 10 percent owner Versant Voyageurs I Parallel, L.p. , and 10 percent owner Versant Venture Capital Vii, L.p. .
Aduro Biotech Inc (ADRO) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Aduro Biotech Inc (ADRO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aduro Biotech Inc (ADRO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Aduro Biotech Inc (ADRO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aduro Biotech Inc Insider Transactions
Eric Dobmeier Mailing Address
Above is the net worth, insider trading, and ownership report for Eric Dobmeier. You might contact Eric Dobmeier via mailing address: C/o Saettle Genetics Inc, 21823 30th Drive Se, Bothell Wa 98021.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
